Bolt on our telehealth ops + marketing team and call center, built to land patients profitably from month 1.
Ten founding seats. When they're gone, these terms are gone. Apply
Month 1 ad budget minimum$30,000 on Meta + Google ($1K a day)

Bolt on our telehealth ops + marketing team and call center, built to land patients profitably from month 1.

Our philosophy: outsource to get going fast, insource when it's time to exit.

Don't let vetting vendors, personnel, and compliance stall what could be done in about three weeks.

Pick a time 30 minutes with the team. On the call we cover:
  1. Your unique advantage and how to build a telehealth brand around it
  2. Our existing marketing results, shown live
  3. The personnel and tools required to run operations for your launch timeline, and the capital your ambition requires

I don't expect you to watch this whole video before applying, but it would be good to read this whole page before doing so.

Are you:

  • A research brand looking to switch to telehealth?
  • A med spa looking to add telehealth?
  • A health entrepreneur wanting to add it for your client base?
  • Or even a telehealth brand that had a rough start, and needs a growth team that knows what it's doing?

Not for you if you can't fund $30,000 of Meta and Google ads in month 1. This is licensed patient care under a brand you own.

See If You Qualify

Not ready to launch? Be an affiliate instead: promote one of our telehealth brands, and we'll support you in promoting it.

01
The problem

Vetting it all yourself stalls the launch.

You've got three options. Two of them are bad.

Option one

Be an affiliate

Send your people to somebody else's brand. They keep the patients, the rebills, and the business. You get a cut, and the day you stop posting, it stops.

Option two

Build it yourself

An attorney, a doctor network, a pharmacy deal, your own LegitScript, a site, a marketing team, a call center, and the compliance to not get fined. Past $50,000 and most of a year of vetting. If you get it right.

This one
Option three

Do it with us

You own the brand, and the machine is already built: doctors, pharmacy, payments, compliance, a marketing team on Meta and Google, and a call center. Outsource to get going fast, insource when it's time to exit. Live and taking patients in about three weeks.

02
The math

Run your numbers.

Before anything else, the money. Put in your ad budget and what a patient costs, or the audience you already have, and how long patients stay. Your monthly profit shows up, with the exit value underneath it. Pick a scenario, or build your own. If we run it for you, you pay once, then nothing until the business clears $50,000 of cumulative net profit. If you run it yourself, there is no share at all.

0≈ 83 new patients a month5M+
0%1,000 patients in year one from your own audience5%
4%a patient stays about 12.5 months15%
$0organic and warm audience only$50k
$100cold traffic in this category runs $250 to $500 a patient$800
$2.5kplatform, software, staff, admin$15k
About $235 kept per patient each month after medication, clinician fees, and processing.
Your monthly profit at steady state
$242,000/ mo
After medication, clinician fees, processing, your ad budget, and fixed business expenses. Before our share.
1,042
Active patients at steady state
$2,938
Lifetime value per patient at this churn
$1.7M
Profit in year one, while the base builds
$14.2M
Illustrative exit value at this size. Your 80%: $11.4M

Same 1,000 clients. One sells at a discount. One sells at scale.

Same 1,000 people, valued two ways. As a research brand they order about $250 every other month, roughly $1.5M a year at the high margins these brands run, and they trade around 3x profit. Licensed, those same people are on a $350 monthly protocol with cross-sells, roughly $4.2M a year, and telehealth trades on revenue. The multiple is a notch better. The monetization is a lot better.

Research-only brand · 1,000 customers
  • Card-network fine risk. One high-risk flag and the $50,000 fines start landing.
  • FDA shutdown risk. A single warning letter can end it overnight.
  • Credit-card processing near 15%, when a processor keeps you at all.
  • Products labeled not for human use, that your customers can't openly take.
  • No cross-sell. You can't add ED, hair loss, HRT, or growth hormone without a license.
  • One processor review from a frozen account and a MATCH-list. The big research brands run seven processors and cycle between them just to stay alive.
  • Hard to build a sales team around, and hard to get referred.
Enterprise value at exit
About $3.3M
About 3x profit, the way research brands trade. Roughly $1.5M a year at the 70 to 78% margins these brands run, so about $1.1M of profit. Verified listings in the category price near 2.3x revenue and 2.9x profit.
Telehealth brand · 1,000 patients
  • Card networks are fine with it. LegitScript certified, no fine risk, no MATCH-list.
  • No FDA shutdown risk. Licensed doctors, valid prescriptions, US pharmacies.
  • Processing near 3%, the rate any legitimate business pays.
  • Licensed medications your patients take in the open.
  • Cross-sell ED, hair loss, HRT, growth-hormone peptides, lab panels, and supplements across the base.
  • $350 a month recurring, clean books a buyer can acquire.
  • Easy to staff a sales team around, and patients refer their friends.
Enterprise value at exit
About $12.6M
About 3x revenue, on $4.2M a year at this scale. Your 80%: about $10M.

Same 1,000 people, and the licensed brand is worth roughly four times more.

Most of the gap is monetization, not the multiple. The licensed brand earns about 2.8x more from the same people, because a $350 monthly protocol with cross-sells beats $250 every other month. The multiple only adds a little on top: roughly 3x revenue for licensed telehealth against about 2.3x for a research brand. A research brand is a good business. This is a bigger one, built on the customers you already have.

And the multiple is earned, not assumed
More buyers

Strategics, private equity, and operators all shop licensed telehealth. A research brand sells into a thin, nervous pool, and a small pool prices low.

Stickier revenue

A monthly protocol with a doctor behind it retains far better than sporadic vial orders. Buyers pay up for revenue that stays.

Lifetime value that grows

Same patient, more to sell: lab panels, supplements, ED, hair loss, HRT. What a patient is worth expands instead of flatlining.

Retention and expansion are what a multiple prices. Which is why 3x is the conservative read here, not the optimistic one.

Illustrative model only. You choose every input, so the output is your assumption, not a projection, forecast, guarantee, or promise of earnings. Per-patient figures assume protocols priced at market (tirzepatide $399, semaglutide $299, hormone protocols $159 to $199) less medication at our negotiated rates, clinician fees, and processing, then the ad budget and fixed business expenses you set (default $5,000 a month), with ad-driven patients costing what you set on the acquisition slider (default $350, the cold-traffic range in this category). Nothing is deducted for our share, which only starts after your cumulative profit clears the threshold on your agreement. Exit value uses roughly 3x revenue once a brand is past $1 million a year, and 3x profit below that. What a company earns or sells for depends on the market, its margins, retention, and execution.

See If You Qualify

Like your numbers? The call is where the team runs them against your market and budget.

03
Our team

You're not betting on one person. You're plugging into a team.

Payments and distribution on one side. Telehealth operations on the other. An operating crew underneath.

Blake Toves

Payments & distribution
  • Processes payments for around 90 brands in this space. Every winner's and every loser's numbers, before anyone else knows something moved.
  • Holds equity in several telehealth brands. Money on the same side of the table as yours.
  • Brokers research-brand exits. Three listed for sale right now, one at $100 million.
  • Created the Peptide Business Summit. The industry already comes to us.

Mark Lombardi

Operations & platform
  • Built and sold multiple companies. A career in data protection for electronic health records, so HIPAA is home turf, not homework.
  • Data provider behind some of the biggest eight and nine-figure GLP-1 brands. He's seen how the winners run from the inside.
  • Owns the category's exact-match domain portfolio. glp-1.com, sermorelin.com, tirz.com, and dozens more, pulling organic traffic every day.
  • Runs the machine. Over a dozen telehealth brands worked with, plus the platform, the pharmacy relationships, and the operating team behind every launch.

Behind them, the operating crew. A marketing team on Meta and Google, a call center working every lead, finance, patient-side care coordination, cart recovery, creative, and vendors.

Our biggest payday is your exit. When we run it for you, we charge once for the build, then share in the profit and take 20% of the sale. Both are worth nothing unless the brand works, and the big one only lands if it's worth buying.

The domain portfolio pulls organic traffic today, and it sells as one block to a strategic buyer tomorrow.
glp-1.com sermorelin.com tirz.com bpc-157.co tb500.org cjc-1295.com ss-31.com semax.com follistatin.net tesamorelin.co ghk-cu.com + dozens more

sermorelin.com alone already draws around 20,000 organic visitors a month.

The brands we work with.

Not mockups. Live category properties, pulling organic traffic right now. Tap one.

The buyers this is built to sell to
Hims · Ro · 30 Madison · Eli Lilly · Novo Nordisk, the strategics who need distribution.

You keep the equity in your own brand, and you can exit it on your own. Mark and I hold 20% of the upside on every brand we run, plus the domain portfolio and the distribution, and we take all of it to one big exit together. We get paid for the build along the way, but the prize we're playing for is the same one you're playing for.

The same 20% on the profit and on the sale. Neither pays until the business does.

Everyone else selling a platform is saying buy from us, and good luck. Here's the keys, good luck driving this rocket ship. Oh, I'm not an astronaut. I'm going to crash. That's what most of these brands end up doing.
Mark, operations partner, on the other platforms
04
The build

Everything between you and a live brand, handled.

Each of these is a wall that stops people from ever starting. We take all of them down in the build, and the build is the same however much of it we run afterward.

Entity & banking

Wyoming LLC, business bank account approved in about a day, Stripe live before LegitScript, legally.

LegitScript, managed

Application prepped and filed in week one, driven to certification in about two to three weeks. It is the gate to going live.

Brand & site

Name, domain strategy, and a conversion-built site, live and compliant.

Platform at floor rate

White-label telehealth platform at our negotiated rate, catalog at cost, zero markup.

Full tech stack

Tracking, email, text, automations, live dashboards, and a Slack channel with our team inside.

Hero product funnel

Your intake funnel launched with paid traffic behind it from day one, built around the one or two products you lead with.

Marketing team + call center

Meta and Google campaigns built and managed on your budget, and a call center working every lead that stalls before finishing intake.

Retention engine

Refill automations and win-back flows from day one. Recurring revenue is the asset; this defends it.

Operating team

Finance, patient-side care coordination, cart recovery, creative, from Day 30. Insource any of it when it's time to exit.

Exit readiness

Quarterly audits keeping your books the way an acquirer reads them, from month one, when we run it for you.

"I'll just buy a platform" is really one of these three.

The same decision, mapped side by side.

A platform, aloneA platform + an agencyThe launched brand, with the teamus
Who builds your brandYou, aloneThe agency, at their paceOur team, in week one
Who gets you certifiedYouUsually nobodyUs, filed in week one
Who brings the first patientsNobodyAds, once you fund themOur marketing team and call center, on your ad budget, from launch day
Who runs it after launchYouYou; they run the adsYou with us on call, or our operating team, decided on your call
How they get paidSetup, then fees on every order, win or loseEvery month, win or loseOnce for the build; a share only if we run it and only after it clears a profit threshold
Who is paid to help you sellNobodyNobodyWe are, when we run it. Books kept diligence-ready from month one, and our share only pays if the sale happens
05
The order of operations

What happens the moment you pay.

Three things, in this order. No patients move until the third one clears, and we would rather you knew that now than found out on the call.

1

We build your brand and site to spec.

An onboarding call to pull your brand references, your hero products, and the people in your orbit. Then about a week of build: the deck, the logo, the custom site, the intake wired to the prescriber network and pharmacy. Built to your brand, not a template with your name on it.

2

LegitScript is filed on that site, and we wait for it together.

Certification is the gate. Nobody onboards a patient until it clears, and it usually takes two to three weeks. That window is not dead time: your entity, bank, processing and ad accounts go up, you train on the platform, and the launch assets get made. But no patient, no prescription, no charge until the certificate is in hand.

3

Certified. Now the launch runs.

Intake opens, the first campaigns go out, and the daily calls run until your first ten patients. Paid traffic runs from day one on your Meta and Google budget, the marketing team optimizes it, and the call center works every lead that stalls. Any audience you bring gets a launch push on top. Section 06 is your job description from here.

06
Who runs what

You're the CEO. We're your operating team.

One company, one chart. You own the brand, the entity, the ad budget, and every strategic call. We sit under you as the fractional COO and CTO, with customer service under us. Clinicians sit beside the company, not under anyone, because they prescribe on their own judgment. The only decision left is how much of the recurring list we run for you, and that is decided on your call.

You, the CEOOwner of the brand, the audience, the entity, the ad accounts, the money.
Telehealth Launch Team, fractional COO and CTORuns the operation and the technology. Reports to you.
Customer servicePatient support, refills, cancellations, win-backs.
Operations and technologyPlatform, prescriber routing, pharmacy, processing, site, automations.
GrowthMarketing team on Meta and Google, a call center working your leads, email and SMS, creators, and affiliates.
Prescriber network and pharmaciesIndependent and licensed. Contracted, never directed.
VendorsPlatform, processor, LegitScript, ad platforms. All substitutable. Our fee does not change when you switch.

Once, at launch

  • Onboarding call: entity, domain, brand references, hero products, ad budget, and any list or creators you already have
  • Hero product isolation: the one or two verticals you launch with
  • Brand deck, logo, custom site, intake wired end to end
  • Prescriber network and pharmacy connected, routing by product and state
  • LegitScript prepared and filed in week one
  • Processing account, whitelisted ad accounts, pixels, tracking
  • Business associate agreement before any patient data moves
  • Meta and Google campaigns built, call center scripts and lead routing set up
  • Launch-week email and SMS, plus a push to any list or audience you bring
  • Media setup call and first campaigns launched in your account
  • Affiliate map, refill and win-back automations, forecast session

Every week and every month

  • Daily: patient support, order flow check, ad account check
  • Weekly: mastermind call and Slack, KPI report, creator content, email and SMS
  • Monthly: ad scaling and creative refresh, call center review, affiliate recruitment and payouts, forecast against actuals, processor and chargeback review, compliance sweep
  • Quarterly: a new vertical, vendor rate review, exit-readiness check
  • Yearly: LegitScript renewal

Run this list yourself with us on call, or we run it as your operating team and share in the upside. Same build either way. Which one fits you is the team's recommendation on your call.

Optional

You don't have to be the face. Front it yourself if you want to, put a creator on it, or stay behind the brand entirely. You fund the ad budget. Everything else is on us.

07
The two offers

Same build. Two ways to run it.

Every brand gets the same build: site, funnel, LegitScript, rails, network, launch. The difference is who runs the business after launch and how the team is paid. Terms are set on your call.

Done with you

The Launch Sprint

One flat engagement, paid once. No equity, no profit share, no monthly fee. The team is in it with you for a fixed term of three or six months, then you run it alone.

The build, by milestone

  • Day 14: custom site built LegitScript-ready, brand deck and logo, intake funnel wired to the platform, launch event built, hero product chosen
  • Day 21: LegitScript application prepared and submitted; entity, banking and processing filed; physician network (all fifty states) and pharmacy catalog connected at our negotiated rate, no markup
  • Day 30: agency ad account live, email and SMS launch sequences loaded, three influencer introductions, media buying setup call, comment automation wired
  • Within two weeks of certification: first campaigns and creator content live on a budget you fund, affiliate map session, forecast session from your numbers

Through your term

  • Weekly mastermind call and Slack access to the team
  • Daily calls until your first ten patients
  • You run the business, the ad account and the customer support, with us on call

What you keep

  • Everything. The brand, the site, the data, the accounts, and 100% of the profit and the exit.

Not included

  • LegitScript's fee (about $4,000), per-order pharmacy, clinician and processing charges, your ad and creator budget, formation and counsel. All paid by you at cost, no markup.
Done for you

The Partnership

A subsidised startup cost, paid once, then the team runs the company with you and is paid only from profit: a monthly operating minimum or a share of net profit, whichever is greater, after the business clears a profit threshold. Plus a share of the exit if you ever sell.

The build, by milestone

  • The same four milestones as the Sprint, on the same dates, with the same refund schedule if one is missed
  • LegitScript managed end to end, with a 90-day money-back backstop if it is refused

The operating team, for the life of the deal

  • Fractional COO and CTO: platform administration, prescriber and pharmacy relationships, processing, site, automations
  • A dedicated customer experience person: patient support, refills, cancellations, win-backs
  • Growth: a marketing team managing Meta and Google in your accounts, a call center working your leads, creatives, email and SMS, affiliates, creators
  • Finance and exit readiness: monthly statement inputs, quarterly clean-up, so the books read the way a buyer reads them
  • Weekly call, Slack answered within one business day, daily calls until patient ten, upstream changes in writing within 24 hours
  • Telehealth platform licence inside the operating minimum, never per order

What you keep

  • 100% of the stock and 100% of control. No shares, no votes, no board seat. Our share is a contract, it cannot block a sale or a raise, and you can buy it out after a set number of months.

Not included

  • The same pass-through costs as the Sprint, at cost. We never fund or take a cut of your media or creator spend.
Who runs it after launchSprint: you, with us on call for your term. Partnership: our operating team, for as long as the deal runs.
How the team is paidSprint: one fee. Partnership: a subsidised fee, then only from profit, plus a share of the exit.
GuaranteesBoth carry the milestone refund schedule and the 10-Patient Pledge. The Partnership adds the LegitScript backstop and the Skin-in-the-Game guarantee.
Who it fitsSprint: you want to operate it yourself. Partnership: you want to be the CEO and let a team operate it.
08
The edge

The drugs are the same everywhere. The edge is everything around them.

Every starter platform carries the same short menu: semaglutide, tirzepatide, testosterone, and the same pills everyone has seen a hundred ads for. Identical brands, identical products, margin bleeding out on price. Three things separate yours.

The formulary

We partner with doctor networks that prescribe what the big platforms won't touch: BPC-157, GHK-Cu, NAD+, sermorelin, TB-500, CJC-1295, and a formulary that runs dozens deep. Most are not FDA-approved, and nobody pretends otherwise. Doctors prescribe them on their own clinical judgment, where their state boards allow it, and because many of these compounds can't be patented, no pharma giant has a billion-dollar reason to clear the field.

The labs

The drugs are commodities. The difference is the blood work: full panels, read by a licensed team, turned into a plan for each patient. People stay because somebody is tracking what's happening in their body. A research brand can't even suggest a blood test without implying human use.

What's coming

A licensed brand gets to bolt on the next generation of medicine as it lands: advanced lab assessments, less invasive mitochondrial testing, AI-assisted diagnostics. Every new tool raises what your brand is worth. Research brands are locked out of that entire world.

BPC-157GHK-CuNAD+SermorelinTB-500CJC-1295+ dozens more
Ninety days from now

What it feels like once it is running

Patients rebill every month whether you worked that day or not. Your revenue arrives on a schedule instead of starting from zero every morning. Your business has a clean profit and loss, the kind a buyer reads and likes.

And you are not refreshing a processor dashboard praying it still works, because nobody freezes a doctor writing a valid prescription. You own something now. Not a hustle that can disappear. An asset you could sell. And every quarter, your books get reviewed the way an acquirer will one day read them, because a team that shares in your exit has every reason to keep you sellable.

And the peptide wave hasn't broken yet. GLP-1s are already racing toward 50% adoption. Peptides are still under 5%, the exact spot GLP-1s were in right before they went mainstream. Every fitness influencer is about to be talking about peptides, and Washington is deciding on peptide compounding right now, with the card networks, the banks, and the VCs all waiting on the answer before the money floods in. Get in front of the wave now, and you are the brand everyone else chases later.

09
The guarantees

Three guarantees. In writing.

They come with the operated seat, and the refund schedule comes with every agreement.

The Launch Guarantee

Live and taking patients when LegitScript clears, with your first campaigns in-market within two weeks of certification and in any case within 45 days of kickoff, or the team keeps working at no further cost until it's done. Late weeks are on us. (Your side: brand decision made early, documents signed on schedule, training attended.)

The 10-Patient Pledge

Daily calls with our team until your first ten patients are in. However long it takes.

The Skin-in-the-Game Guarantee

Our share is worth zero if your brand goes nowhere. The fee pays for the build; the share only pays if you win. Their guarantee is a refund policy. Ours is the deal itself, plus a milestone refund schedule written into every agreement.

Apply for a seat

All three come with the seat. Booking a call takes a minute.

10
Who it's for

Who this is for, and who it isn't.

This is for you if

  • You can fund $30,000 of Meta and Google ads in month 1, about $1K a day
  • You run a research brand and already know the products, the buyers, and the compliance line
  • You are a coach, creator, med spa, or clinic whose people already ask about GLP-1s, hormones, or peptides
  • You want a licensed brand you own and can sell, not an affiliate link
  • You are launching in the United States

This is not for you if

  • You want a guarantee of patients or revenue. Nobody honest can give you one, and we won't
  • You want to sell research peptides on the same brand. They stay on their own entity and domain
  • You can't fund the $30,000 month 1 ad budget
  • You want to direct the doctors. Clinicians prescribe on their own judgment, and that is what keeps the brand legal
Answers

The questions every operator asks before signing.

Do I have to be the face, or be on camera?
No, and plenty of owners never appear anywhere. Some front the brand themselves, some hand it to a creator, some stay entirely behind it. What the offer needs is the ad budget: our marketing team and call center bring the patients. Whether there is a face at all is yours to decide.
Do I need a medical license?
No. Licensed doctors write the prescriptions, licensed pharmacies fill them, and platform partners carry the clinical compliance. You own the brand and the customer relationships. You never practice medicine.
Who holds the medical liability?
The licensed providers and the platform partners who stand behind them, not you. You run marketing and own the brand; you never write a prescription or give medical advice, so the clinical risk never sits on your side of the table.
Do I own this outright? Whose customers are these?
Yours. Your LLC, your bank account, your Stripe, your website, your list. We never market to your patients. You can sell the whole company, customers included, whenever you want.
Why would I give up 20%?
You only do when we run it for you, and then flip the question. Why is the platform at our negotiated rate, the catalog with no markup, no upsells on anything, and you're only paying for the team? Because we're participating in the upside with you. Our share carries no votes and no board seat, and where else can you find a team that's going to run this with you and stake 20% of its own upside on your exit? It doesn't exist.
Do you run it for me, or do I run it?
Either. The build is the same. After launch you can run the recurring list yourself with our materials, weekly calls, and the team on Slack, one flat engagement and no share. Or we sit in as your operating team and run it, in which case you pay once for the build, then nothing until the business clears $50,000 of cumulative net profit, then the greater of a monthly minimum or 20% of net profit, plus 20% of the exit. The team recommends one on your call once we've seen your market, your ad budget, and your numbers, and exact terms are quoted there.
What if it doesn't work, or I want out?
Every agreement carries a milestone refund schedule: a full refund until the first milestone is delivered, then a declining schedule as milestones land. Miss a milestone by more than fourteen days and we get thirty days to cure or you leave without penalty. If we run it for you, there is also a LegitScript backstop. And it's a company you own, not a login on someone else's platform, so you can slow down, sell, or walk.
Can't I just go direct to a platform myself?
You can, and you'd pay about the same fee for the keys and a good-luck email. No support, no CX, no marketing team, no call center, and the platforms won't tell you what works because they're protecting their alpha. We make nothing on the platform. What you're paying for is the team that hand walks you through it and shares everything.
Are the medications and peptides legitimate?
Yes. Prescribed by licensed doctors and filled by licensed US compounding pharmacies. No research-only peptides. The formulary runs deep, from GLP-1s to BPC-157, GHK-Cu, NAD+, sermorelin, TB-500, and CJC-1295, all under a licensed doctor's clinical judgment.
Is this legal?
Yes. Licensed doctors, valid prescriptions, US pharmacies, LegitScript (the certification the card networks require), FTC-clean marketing. That legitimacy is exactly what makes the brand sellable.
What does it run month to month?
Nothing to us until the business is working. If we run it for you, nothing is owed until it clears $50,000 of cumulative net profit. After that the operating team is paid a monthly minimum or 20% of net profit, whichever is greater that month, and that is what funds the people running it. If you run it yourself there's no monthly and no share at all. Either way you carry the normal costs of any telehealth business: pharmacy per order, clinician fees, processing, and your ad budget. Those pass through at cost, all visible, nothing sprung on you later.
How much ad budget do I need to start?
$30,000 for month 1, about $1K a day across Meta and Google. That is the minimum we take on, because the marketing team and call center need enough traffic in the first month to learn what converts for your brand. The media budget is yours throughout: it goes straight to the platforms, your account, your control, and we take no commission on it.
How fast am I live?
About three weeks. The site, brand, and intake are built in week one and LegitScript is filed the same week. Certification takes two to three weeks, and you go live taking patients when it clears. The written backstop is the Launch Guarantee: campaigns in-market within two weeks of certification, or we keep working at no further cost.
What happens when I want to sell?
That's the point. When we run it for you we keep your books diligence-ready from month one, and our share is a contract that sits outside your cap table, so it can't block a sale. You can sell to us, to a strategic, to anyone. Your company, your call.
Why only ten?
The operating team is people, not software, and ten brands is what it can carry at once. These founding terms exist for the first ten brands we run. When the seats fill, the founding terms end.

Patients are already buying this. The only question is from whose brand.

Ten founding seats for the brands we run. Grab a time below. On the call, the team looks at your market and budget, maps your launch, and runs your numbers, and you know by the end of it, either way.

Apply for a seat